Product: | Nelfinavir Mesylate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 12476 | ||||||||
CAS Number: | 159989-65-8 (anhydrous) | ||||||||
Synonyms: |
(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquino; AG-1343; Nelfinavir; Viracept |
||||||||
Pricing: |
|
||||||||
Formula: | C32H45N3O4S • CH3SO3H • xH2O | ||||||||
Chemical Purity: | >98% | ||||||||
Molecular Weight: | 663.89 | ||||||||
Structure: | |||||||||
Appearance: | Powder | ||||||||
Category: | Anti-viral Compounds | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2-8°C |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Bernstein, W.B., and Dennis, P.A., Repositioning HIV protease inhibitors as cancer therapeutics. Curr. Opin. Immunol. 3, 666-675, (2008); Merck 14,6443 |
||||||||
MSDS: | |||||||||
Description: |
Nelfinavir is a HIV protease inhibitor; antiretroviral; and anti-tumor agent |